While GLP-1 receptor agonists have been studied in clinical trials, its important to note that compounded versions do not undergo the same regulatory review as FDA-approved medications
Findings revealed that patients were able to take lower dosages of insuline and had fewer episodes of hypoglycemia
Gene modulation and cellular repair BPC-157 works at the cellular level, boosting cellular repair by influencing gene expression
Because these two types of medications serve completely different purposes, they do not usually cancel each other out. However, Wegovy does change how your body processes anything you swallow, which is where the nuances of the interaction begin
( Semantic Scholar ) Translation: its not fake. Its also not miracle. Its promising, plausible, and very marketable which is exactly why it will trend
References (15) Adeoye O, Olawumi J, Opeyemi A, et al